Nanomedicine Delivers RNA to Cells for Protein Therapy
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Nanomedicine uses nanocarriers to transport RNA into cells, turning cells into drug‑producing factories.
- mRNA serves as a temporary blueprint that ribosomes read to synthesize therapeutic proteins inside the cell.
- RNA interference (siRNA/ASO) can silence harmful protein production, providing a precise regulatory tool.
- Factor VIII deficiency (Hemophilia A) could be treated by delivering RNA that boosts its production, reducing bleeding risk.
- ApoC3 overproduction leads to high triglycerides; nanomedicine can down‑regulate it, lowering heart disease risk.
Why it matters: Nanomedicine could let Hemophilia A patients produce Factor VIII internally, reducing weekly injection dependence.
Ask SkimNews
